Colombia, pursuing healthcare savings, plots compulsory license for ViiV's HIV drug dolutegravir
Fierce Pharma
OCTOBER 4, 2023
After sparring with GSK’s ViiV Healthcare over the price of its HIV medication dolutegravir, Colombia appears to be taking matters into its own hands. The idea behind the compulsory license is to allow the Colombian government to purchase cheaper generic versions.
Let's personalize your content